Adamas Pharmaceuticals, Inc. (ADMS) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $17.36 to $18.04 over the past one-month time frame.
The stock has witnessed one upward and one downward estimate revision in the past 30 days. The Zacks Consensus Estimate has moved up over the same time frame, suggesting that more solid trading could be ahead for Adamas Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if the latest jump can turn into more strength down the road.
Adamas Pharmaceuticals carries a Zacks Rank #1 (Strong Buy), while its Earnings ESP is 0.00%.
Investors interested in the med-generic drg industry may also consider Amphastar Pharmaceuticals, Inc. (AMPH), sporting a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment